# Hematotoxicity in Maintenance Therapy of Children With Acute Lymphoblastic Leukemia

> **NCT03255668** · — · COMPLETED · sponsor: **Indonesia University** · enrollment: 106 (actual)

## Conditions studied

- Mercaptopurine Adverse Reaction
- Leukemia, Lymphoblastic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03255668
- **Lead sponsor:** Indonesia University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-25
- **Primary completion:** 2018-10-15
- **Final completion:** 2018-11-01
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2018-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03255668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03255668, "Hematotoxicity in Maintenance Therapy of Children With Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03255668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*